|
|
Volumn 1, Issue 1, 2003, Pages 40-45
|
|
New treatments for erectile dysfunction
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
ANTIANDROGEN;
ANTIDEPRESSANT AGENT;
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
CARBAMAZEPINE;
CIMETIDINE;
CLOFIBRATE;
CYCLIC GMP;
CYPROTERONE ACETATE;
DESIGNER DRUG;
DOXEPIN;
FINASTERIDE;
FLUTAMIDE;
GONADORELIN;
LEUPRORELIN;
LEVODOPA;
NEUROLEPTIC AGENT;
NEUROTRANSMITTER;
NITRIC OXIDE;
PHENELZINE;
PHENYTOIN;
PROLACTIN;
PROSTAGLANDIN E1;
SILDENAFIL;
TADALAFIL;
TESTOSTERONE;
UNINDEXED DRUG;
VARDENAFIL;
YOHIMBINE;
AGING;
ALCOHOLISM;
ARTICLE;
BACKACHE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CIGARETTE SMOKING;
COLOR VISION DEFECT;
DISEASE MARKER;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG TARGETING;
DYSPEPSIA;
ERECTILE DYSFUNCTION;
FLUSHING;
HEADACHE;
HORMONAL THERAPY;
HUMAN;
LABORATORY TEST;
MALE;
MEDICAL ASSESSMENT;
MEDICAL EXAMINATION;
PATHOPHYSIOLOGY;
PATIENT COUNSELING;
PHYSICAL EXAMINATION;
POPULATION RESEARCH;
PRIORITY JOURNAL;
RHINITIS;
RISK ASSESSMENT;
SEXUAL BEHAVIOR;
SIDE EFFECT;
UNITED STATES;
VASCULAR DISEASE;
VASCULAR SURGERY;
VASOMOTOR DISORDER;
VISUAL DISORDER;
|
|
EID: 13344268906
PISSN: 15462501
EISSN: None
Source Type: Journal
DOI: 10.1016/j.sram.2004.02.023 Document Type: Review |
|
Times cited : (5)
|
|
References (8)
|
